SoCalBio Vendor Spotlight
JP Tech Insurance Services, Inc.
A SoCalBio Member Since 2002
Led by Mr. Joseph Plascentia (photo above), JP Tech Insurance Services, Inc. provides insurance and risk management services to the biotechnology and medical device industries ... Learn more
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
Thanks to SoCalBio Media Partners
|
|
|
February 19, 2013
| Editor: Ahmed Enany President & CEO Southern California Biomedical Council enany@socalbio.org www.socalbio.org
|
Featured Story
|
The Los Angeles-Based Second Sight Wins FDA Approval of its Breakthrough Implantable Bionic Eye
 Second Sight Medical Products has won FDA approval for its Argus II bionic eye for the treatment of late stage Retinitis Pigmentosa (RP). This announcement comes after the European approval in 2011, and widespread support from the FDA's Ophthalmic Devices Advisory panel. The Argus II system was apparently shortlisted for approval under the Humanitarian Device Exemption, which has been put in place to expedite technologies for under-served patient populations. "We are thrilled to be able to offer the only FDA-approved long-term therapy for people suffering from advanced RP," said Robert Greenberg, MD, PhD (photo right), President and CEO of Second Sight. "With this approval, we look forward to building a strong surgical network in the United States and recruiting new hospitals that will offer the Argus II retinal implant. This is a game changer in sight-affecting diseases, that represents a huge step forward for the field and for these patients who were without any available treatment options until now" ... Read company Press Release Watch YouTube Video about Second Sight's Breakthrough Device
|
Crowdfunding |
Crowdfunding for the Biosciences:
A Real Prospect or Pipe Dream
CNSI Auditorium at UCLA
570 Westwood Plaza, Los Angeles, CA 90095
Thursday, February 28, 2013 from 4:00 PM to 7:00 PM
Crowdfunding promises to give some startups access to capital they wouldn't have had otherwise, but it could also set up unprepared entrepreneurs for a headache. This SoCalBio mixer will provide a primer on this source of funding and discuss all the legal, accounting, and business strategy aspects of crowdsourcing for bioscience commercialization projects.
Our Speakers and panelists will touch on:
- How to crowdfund by reaching out to people in your network
- How to tap into their desire to support your project and believe in your claims
- How to keep crowdfunding legal
- Are there crowdfunding best practices?
- Is it realistic to crowdsource for biotech or medical device projects?
- Will crowdsourcing hurt your chances of tapping into institutional money
Speakers
- Howard Leonhardt, Founder & Chairman, California Stock Exchange
- Carl Esposti, Founder Crowdsourcing.org & CEO, Massolution
- David Harvilicz, Founder & CEO, WhenYouWish.com
Panel Discussion
- Joseph A. Boystak, President & CEO, Brightwaters Capital
- George Colindres, Sr Counsel, Perkins Coie
- Eric Miles, Partner, Moss Adams
- Roger Zickfeld, Managing Director, Zickfeld Capital Advisors
|
Public Policy |
Healthcare reform: What Should the Medical Device Industry Expect from the Sunshine Act?
A Mass Device interview with Jonathan Kellerman, compliance and risk management expert at PricewaterhouseCoopers about the Sunshine Act. Kellerman contends that medical device companies should brace for some unintended consequences after the Centers for Medicare & Medicaid Services announcement of the rules in relationship to the Physician Payment Sunshine Act .... Read more
|
Emerging Markets |
The Far East Is Becoming the Wild West for Med-tech
Medtronic's acquisition of Changzhou Holdings and Stryker's decision to buy Trauson Holdings signal an emerging trend of companies eager to dip into new markets in 2013, especially China ... Read more
|
Join SoCalBio |
Become a SoCalBio Member and Save Money by Utlizing the SoCalBio Group Purchasing Program

|
New Incubator
|
Former Amgen Scientist Starts an Incubator in Thousand Oaks
The San Fernando Valley Business Journal featured the new incubator started in Thousand Oaks by Greg Cauchon (photo right). The incubator is called the New Ventura BioCenter. This incubator provides wet-lab and office space for short- or medium-term lease. The BioCenter helps startup firms accelerate their discovery and development efforts through to a successful exit ... Access article (requires subscription)
|
New Funding
|
The Goleta-Based Obesity Device Company BaroNova Raises $27 Million
 This C round for weight loss device maker BaroNova is led by Boston Scientific, Sante Ventures, Lumira Capital and a bevy of other venture capital shops. BaroNova is developing a "transpyloric shuttle," inserted endoscopically into the stomach to slow digestion and create a feeling of satiety which should slow or stop patients from overeating ... Read more Other Recent Greater Los Angeles Venture Funding Deals - The Marina del Rey-Based Tribogenics Raises $6.2 Million Series A Round Led by Founders Fund ... Read more
- The Laguna Hills-based Glaukos Corp., a developer of a glaucoma device, has raised $30 million in new VC funding ... Read more
- The Irvine-based Ivantis, a developer of glaucoma stent, has raised $27 million in a first closing of its Series B funding ...Read more
|
Supported Event |
Biomed Innovation Summit 2013
14-15th March, 2013 SHANGHAI, CHINA
|
|
Patenting
|
Stellar Biotechnologies Files Provisional Application for Patent for KLH Adjuvant Innovations
The new innovations are related to Stellar's Keyhole Limpet Hemocyanin ("KLH")-based combinatorial adjuvant technology. The application included claims for pharmaceutical grade adjuvant compositions, manufacturing processes and uses in a wide range of vaccine therapies ... Read more
|
Biotech Real Estate Opportunity |
Rare Biotech Sublease Opportunity in Santa Monica
Approx 28,000 Total Contiguous Rentable Square Feet
- Asking rate: $2.50 NNN with 3% annual increases
- 1545 17th St. approximately 18,000 rsf. through September 30, 2016
- 1701 Colorado Ave. / 1553 17th St. approximately 10,000 rsf through October 31, 2016
- Longer terms may be available
- Available December 1, 2013
- Creative office potential
- Two buildings combined currently improved as a biotechnology manufacturing facility, including: generator, clean rooms, laboratory space, hoods, autoclaves, etc
- Approx. 62 car parking (including lot across the street at 1544 17th St.)
- Located in the heart of the Santa Monica Media District and across the street from a future Metro stop
|
New SoCalBio Members |
Globizz (Gardena)
Globizz is an international consulting company with extensive experience in cross-border business. The company provides strategic planning and risk management services to Japanese companies interested in expansion in the US and American companies interested in doing business in Japan... Learn more
Interlean LLC (Lawndale)
Interlean is created by Mr William Botha, formerly with Baxter Biosciences and Avrio Biopharmaceuticals, to offer Lean deployment services customized to fit the needs of the tightly regulated pharmaceutical and medical device companies ...learn more
Quantason (Los Angeles)
Quantason has developed a revolutionary, next-generation bi-modal (US/IDUS) platform technology which fundamentally changes the utilization of conventional ultrasound both as a modality for diagnostic imaging and as an active screening method ... Learn more
Amethyst Life Sciences
@ the New Ventura BioCenter (Thousand Oaks)
Amethyst Life Sciences, Inc., is a privately-funded company whose mission is to enable new start-up businesses in the areas of biotechnology, pharmaceutical science, nanotechnology, and materials science ... Learn more
Exact Staff, Inc. (Woodland Hills)
Exact Staff is a healthcare and medical device staffing service provider. The company will be represented in SoCalBio by its CEO Ms. Karen Goodwin kgoodwin@exactstaff.com ... Learn more
|
Jobs Available |
Avita Medical (Northridge)
Helix Medical (Baldwin Park)
AMSBIO (Lake Forest)
Quantason (Los Angeles)
|
|
About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|